tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AKTX Stock Latest News

Akari Therapeutics appoints Farag as interim CFO
The FlyAkari Therapeutics appoints Farag as interim CFO
2d ago
AKTX
Akari Therapeutics announces presentation of mechanism of action data for PH1
PremiumThe Fly
Akari Therapeutics announces presentation of mechanism of action data for PH1
10d ago
AKTX
Akari Therapeutics announces abstract on PH1 mechanism-of-action data
PremiumThe Fly
Akari Therapeutics announces abstract on PH1 mechanism-of-action data
16d ago
AKTX
Akari Therapeutics announces formation of SAB
PremiumThe Fly
Akari Therapeutics announces formation of SAB
21d ago
AKTX
Akari Therapeutics Appoints Kameel Farag as Interim CFO
PremiumCompany Announcements
Akari Therapeutics Appoints Kameel Farag as Interim CFO
28d ago
8K
AKTX
Akari Therapeutics launches CEO Corner platform
PremiumThe FlyAkari Therapeutics launches CEO Corner platform
29d ago
AKTX
Akari Therapeutics Announces $2.5 Million Direct Offering
Premium
Company Announcements
Akari Therapeutics Announces $2.5 Million Direct Offering
1M ago
8K
AKTX
Akari Therapeutics Announces $2.5 Million Direct Offering
Premium
Company Announcements
Akari Therapeutics Announces $2.5 Million Direct Offering
1M ago
8K
AKTX
Akari Therapeutics prices 3.13M ADSs at 80c in registered direct offering
PremiumThe Fly
Akari Therapeutics prices 3.13M ADSs at 80c in registered direct offering
1M ago
AKTX
Akari Therapeutics files two new patents with USPTO
PremiumThe Fly
Akari Therapeutics files two new patents with USPTO
1M ago
AKTX
Akari Therapeutics Completes August 2025 Notes Offering
PremiumCompany Announcements
Akari Therapeutics Completes August 2025 Notes Offering
2M ago
8K
AKTX
Akari Therapeutics Reveals Promising Preclinical Data for PH1
PremiumCompany Announcements
Akari Therapeutics Reveals Promising Preclinical Data for PH1
2M ago
8K
AKTX
Innovative Cancer Treatment Approach Drives Buy Rating for Akari Therapeutics
PremiumRatingsInnovative Cancer Treatment Approach Drives Buy Rating for Akari Therapeutics
2M ago
AKTX
Akari Therapeutics announces preclinical data on PH1
Premium
The Fly
Akari Therapeutics announces preclinical data on PH1
2M ago
AKTX
Akari Therapeutics Stock (AKTX) Rises after Filing Patent for Novel Cancer Therapy
Premium
Market News
Akari Therapeutics Stock (AKTX) Rises after Filing Patent for Novel Cancer Therapy
2M ago
AKTX
Akari files for patent on ADC platform using spliceosome payload PH1
PremiumThe Fly
Akari files for patent on ADC platform using spliceosome payload PH1
2M ago
AKTX
Akari Therapeutics’ Strategic Shift and Innovative ADC Platform Earns Buy Rating Despite Financial Constraints
PremiumRatings
Akari Therapeutics’ Strategic Shift and Innovative ADC Platform Earns Buy Rating Despite Financial Constraints
2M ago
AKTX
Akari Therapeutics Enters Share Purchase Agreement
PremiumCompany Announcements
Akari Therapeutics Enters Share Purchase Agreement
3M ago
8K
AKTX
Akari Therapeutics Cancels Peak Bio Note and Loan
PremiumCompany Announcements
Akari Therapeutics Cancels Peak Bio Note and Loan
3M ago
8K
AKTX
Akari Therapeutics Releases Updated Investor Presentation
PremiumCompany AnnouncementsAkari Therapeutics Releases Updated Investor Presentation
3M ago
8K
AKTX
Buy Rating for Akari Therapeutics: Promising ADC Innovations and Growth Potential in Oncology
Premium
Ratings
Buy Rating for Akari Therapeutics: Promising ADC Innovations and Growth Potential in Oncology
3M ago
AKTX
Morning Movers: Under Armour sinks following second quarter earnings
Premium
The Fly
Morning Movers: Under Armour sinks following second quarter earnings
3M ago
UA
AMR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >